Peptide Mixture Analysis via Depolymerization and Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for analytical methods to characterize complex peptide mixtures, such as glatiramer acetate, which contain amino acids like glutamic acid, alanine, tyrosine, and lysine, particularly to detect and quantify modifications at the C-terminus, including the presence of diethylamide groups, to ensure batch consistency and quality control.

Innovation Solution

The method involves analyzing samples using techniques like liquid chromatography, mass spectrometry, NMR spectroscopy, and antibody detection to identify and quantify diethylamide moieties at the C-terminus of peptides and polypeptides, including depolymerization and purification steps to liberate and detect diethylamine, allowing for comparison to reference values for pharmaceutical use.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If complex peptide mixtures are analyzed using conventional methods, then structural characterization is limited, but measurement precision and detection capability are insufficient

Engineering Contradiction:
Improvedetection capabilityVSAvoidmethod complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The complex peptide mixture analysis is segmented into multiple specialized detection steps: depolymerization to break down the copolymer into constituent peptides, followed by specific detection methods (NMR, mass spectrometry, liquid chromatography) to analyze different aspects of the mixture. This segmentation allows each method to focus on specific structural features, improving overall measurement precision without requiring a single overly complex instrument

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs intermediary substances and processes to facilitate detection. Depolymerization reagents convert the complex copolymer into smaller, more detectable peptide fragments. Derivatization agents are used to enhance the detectability of specific functional groups. These intermediaries bridge the gap between the complex original sample and the detection instruments, improving measurement capability while managing complexity

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If depolymerization and purification steps are added to detect diethylamide modifications, then detection precision improves, but processing time and operational complexity increase

Engineering Contradiction:
Improvemodification detection accuracyVSAvoidanalysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent performs preliminary depolymerization and purification steps before the actual detection of diethylamide modifications. By pre-processing the sample to break down the copolymer and isolate relevant components, the subsequent detection steps become more efficient and accurate. This preliminary action reduces the complexity of the sample matrix, allowing for faster and more precise detection of the target modifications

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent utilizes parameter changes during the analysis process, such as adjusting pH, temperature, and solvent conditions to optimize each step from depolymerization to detection. By optimizing these parameters, the process achieves high detection precision for diethylamide modifications while minimizing unnecessary processing time. For example, specific pH conditions enhance the efficiency of depolymerization and the sensitivity of subsequent detection methods

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables accurate characterization and quality control of complex peptide mixtures by detecting and quantifying diethylamide modifications, ensuring batch consistency and biological equivalence, thereby supporting the production and pharmaceutical use of compounds like glatiramer acetate.

Implementation Method 1

analyzing the sample by a method capable of detecting a modification of at least one C-terminus... liquid chromatography

Methodology Applied
Scientific EffectChromatography: Chromatography

Implementation Method 2

analyzing the sample by a method capable of detecting a modification... mass spectrometry

Methodology Applied
Scientific EffectMass spectrometry:

Implementation Method 3

analyzing the sample by a method capable of detecting a modification... NMR spectroscopy

Methodology Applied
Scientific EffectNMR spectroscopy:

Implementation Method 4

analyzing the sample by a method capable of detecting a modification... antibody detection method

Methodology Applied
Scientific EffectAntibody detection:

Implementation Method 5

depolymerizing or fragmenting the sample... depolymerization and purification steps to liberate and detect diethylamine

Methodology Applied
Scientific EffectDepolymerization:

Data Source

PatentUS8927292B2Methods of evaluating peptide mixtures
Publication Date: 2015.01.06 MOMENTA PHARMACEUTICALS INC
  • US8927292B2 patent drawing
  • US8927292B2 patent drawing
  • US8927292B2 patent drawing

AI summary

The presently disclosed subject matter provides methods for evaluating and characterizing peptides, peptide mixtures, and polypeptide mixtures. More particularly, the presently disclosed subject matter provides methods for evaluating or characterizing complex peptide or polypeptide mixtures comprising glutamic acid, alanine, tyrosine, and lysine, e.g., Copolymer-1 or glatiramer acetate, including, but not limited to, methods of identifying, isolating, quantifying, and purifying amino acids, peptides, polypeptides, and combinations thereof having a diethylamide group instead of a carboxyl group present on the C-terminus. The presently disclosed methods can be used to determine the mole percent of polypeptides having a diethylamide group at a C-terminus thereof and can be used to evaluate one or more properties of a sample of one polypeptide mixture as compared to one or more properties of a different sample of a polypeptide mixture.